triazoles has been researched along with Minimal Disease, Residual in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estey, EH; Percival, MM | 1 |
| Erdenebaatar, C; Katabuchi, H; Miyahara, Y; Motohara, T; Saito, F; Tashiro, H; Yamaguchi, M | 1 |
| Gaballah, K; Hills, A; Oakley, R; Partridge, M; Ryan, A | 1 |
| Bedard, PL; Bradbury, I; Desmedt, C; Dixon, JM; Evans, DB; Haibe-Kains, B; Ignatiadis, M; Loi, S; Michiels, S; Miller, WR; Piccart, MJ; Singhal, SK; Sotiriou, C | 1 |
| Dixon, JM; Majdak-Paredes, E; Raine, C; Schaverien, MV | 1 |
1 review(s) available for triazoles and Minimal Disease, Residual
| Article | Year |
|---|---|
Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia.
Topics: Aminopyridines; Aniline Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Azacitidine; Cytogenetic Analysis; Decitabine; Enzyme Inhibitors; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunologic Factors; In Situ Hybridization, Fluorescence; Lenalidomide; Leukemia, Myeloid, Acute; Molecular Diagnostic Techniques; Neoplasm, Residual; Nivolumab; para-Aminobenzoates; Protein Kinase Inhibitors; Pyrazines; Pyrrolidines; Recombinant Fusion Proteins; Remission Induction; Transplantation, Homologous; Triazines; Triazoles | 2019 |
4 other study(ies) available for triazoles and Minimal Disease, Residual
| Article | Year |
|---|---|
Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.
Topics: Adult; Aromatase; Aromatase Inhibitors; Bone Density; Endometrial Neoplasms; Endometrial Stromal Tumors; Estradiol; Female; Humans; Letrozole; Middle Aged; Neoplasm, Residual; Nitriles; Receptors, Estrogen; Retreatment; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2015 |
The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Neoplasm, Residual; Neoplasms, Experimental; Quinazolines; Triazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Pharmacological; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Proliferation; Cell Survival; Early Detection of Cancer; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Microarray Analysis; Middle Aged; Neoplasm, Residual; Nitriles; Prognosis; Receptors, Estrogen; Time Factors; Triazoles | 2011 |
Therapeutic mammaplasty--extending indications and achieving low incomplete excision rates.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Letrozole; Mammaplasty; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Nitriles; Patient Satisfaction; Retrospective Studies; Treatment Outcome; Triazoles | 2013 |